CFDE Data Portal | Search SINHCAFP3

	Label	Description
	SINHCAFP3 Gene (Entity type)	ENSG00000253488 - SINHCAF pseudogene 3
	GSE143782 calcitriol 7 v 11 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE80098 GSE80366 progesterone 0 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE205714 GSE229013 adenosine 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 cisplatin 11 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE102505 tunicamycin 6 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE152642 GSE153671 KMT2D inhibition 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE68925 fasudil 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE159678 hydroxychloroquine 6 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE218060 decitabine T cell 2 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS

SINHCAFP3

ENSG00000253488 - SINHCAF pseudogene 3

GSE143782 calcitriol 7 v 11 human dn

A Gene Set from LINCS

GSE80098 GSE80366 progesterone 0 v 8 human up

A Gene Set from LINCS

GSE205714 GSE229013 adenosine 3 v 2 human dn

A Gene Set from LINCS

GSE216043 cisplatin 11 v 4 human dn

A Gene Set from LINCS

GSE102505 tunicamycin 6 v 2 human up

A Gene Set from LINCS

GSE152642 GSE153671 KMT2D inhibition 0 v 1 human up

A Gene Set from LINCS

GSE68925 fasudil 1 v 0 human up

A Gene Set from LINCS

GSE159678 hydroxychloroquine 6 v 3 human up

A Gene Set from LINCS

GSE218060 decitabine T cell 2 v 6 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.